AI Predictive Model of Mortality and Intensive Care Unit Admission in the COVID-19 Pandemic: Retrospective Population Cohort Study of 12,000 Patients.

Publication date: Jul 10, 2025

One of the main challenges with COVID-19 has been that although there are known factors associated with a worse prognosis, clinicians have been unable to predict which patients, with similar risk factors, will die or require intensive care unit (ICU) care. This study aimed to develop a personalized artificial intelligence model to predict the patient risk of mortality and ICU admission related to SARS-CoV-2 infection during the initial medical evaluation before any kind of treatment. It is a population-based, observational, retrospective study covering from February 1, 2020, to January 24, 2023, with different circulating SARS-CoV-2 viruses, vaccinated status, and reinfections. It includes patients attended by the reference hospital in Fuenlabrada (Madrid, Spain). The models used the random forest technique, Shapley Additive Explanations method, and processing with Python (version 3. 10. 0; Python Software Foundation) and scikit-learn (version 1. 3.0). The models were applied to different epidemic SARS-CoV-2 infection waves. Data were collected from 11,975 patients (4998 hospitalized and 6737 discharged). Predictive models were built with records from 4758 patients and validated with 6977 patients after evaluation in the emergency department. Variables recorded were age, sex, place of birth, clinical data, laboratory results, vaccination status, and radiologic data at admission. The best mortality predictor achieved an area under the receiver operating characteristic curve (AUC) of 0. 92, sensitivity of 0. 89, specificity of 0. 82, positive predictive value (PPV) of 0. 35, and mean negative predictive value (NPV) of 0. 98. The ICU admission predictor had an AUC of 0. 89, sensitivity of 0. 75, specificity of 0. 88, PPV of 0. 37, and NPV of 0. 98. During validation, the mortality model exhibited good performance for the nonhospitalized group, achieving an AUC of 0. 95, sensitivity of 0. 88, specificity of 0. 98, PPV of 0. 21, and NPV of 0. 99, predicting the death of 30 of 34 patients who were not hospitalized. For the hospitalized patients, the mortality model achieved an AUC of 0. 85, sensitivity of 0. 86, specificity of 0. 74, PPV of 0. 24, and NPV of 0. 98. The model for predicting ICU admission had an AUC of 0. 82, sensitivity of 1. 00, specificity of 0. 59, PPV of 0. 05, and NPV of 1. 00. The models’ metrics presented stability along all pandemic waves. Key mortality predictors included age, Charlson value, and tachypnea. The worse prognosis was linked to high values in urea, erythrocyte distribution width, oxygen demand, creatinine, procalcitonin, lactate dehydrogenase, heart failure, D-dimer, oncological and hematological diseases, neutrophil, and heart rate. A better prognosis was linked to higher values of lymphocytes and systolic and diastolic blood pressures. Partial or no vaccination provided less protection than full vaccination. The artificial intelligence models demonstrated stability across pandemic waves, indicating their potential to assist in personal health services during the 3-year pandemic, particularly in early preventive and predictive clinical situations.

Open Access PDF

Semantics

Original Article